Skip to content

Understanding the efficacy and process of Schema Therapy in individuals having cluster C personality disorders using a multiple baseline research design

Efficacy and Process of Schema Therapy in Individuals with Cluster C Personality Disorders: A Multiple Baseline Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/04/041960
Enrollment
21
Registered
2022-04-20
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F606- Avoidant personality disorder Health Condition 2: F607- Dependent personality disorder Health Condition 3: F605- Obsessive-compulsive personality disorder

Interventions

Intervention1: Schema Therapy: 40-45 sessions of schema therapy, out of which 30 sessions will be biweekly and the rest once a week fading to once a month. Control Intervention1: Not applicable: Not a

Sponsors

National Institute of Mental Health and Neurosciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: •Patients with a diagnosis of a cluster C PD- AvPD, DPD, OCPD, Mixed cluster C PD according to DSM-V criteria with or without mild to moderate Axis 1 •Patients in the age range of 20-50 years •Patients who can speak Hindi and English, however, can read in English. •Patients who are on stable medication or not on any medication before beginning therapy. •Patients who are willing to commit for approximately 8 months of therapy. •Patients who are willing to be a part of the baseline period.

Exclusion criteria

Exclusion criteria: 1.Patients having a diagnosis of Personality Disorder (PD) not otherwise specified as well as mixed PD diagnosis. 2.Patients diagnosed with psychotic disorders, severe Axis 1 conditions (CGIS score equal to or more than 4), clinical evidence for neurodevelopmental disorders, or other neurological, neurosurgical or organic conditions that may interfere with engagement in therapy. 3.Patients with substance abuse disorders who are in need of clinical detoxification. 4.Patients who are undergoing regular psychotherapy for PD in the last 3 months.

Design outcomes

Primary

MeasureTime frame
To examine the efficacy of schema therapy on Personality Disorder severity in patients with cluster C personality disorder using the Levels of Personality Functioning Scale-Brief form 2.0Timepoint: This scale will be administered weekly during the baseline period post which it will be administered before every therapy session till termination

Secondary

MeasureTime frame
To examine the efficacy of schema therapy on EMS and schema mode change in patients with cluster C personality disorder. To examine the efficacy of schema therapy on Emotion dysregulation Interpersonal Effectiveness and psychological distress in patients with cluster C personality disorder. To examine the mediating role of emotion inhibition in the relation between experiential avoidance and cluster PD severity. To examine the role of early maladaptive schemas and schema mode change in decreasing PD severity. To understand the clients experiences of helpful and unhelpful aspects of schema therapy. Timepoint: Baseline Exploration phase Treatment phase Post treatment completion

Countries

India

Contacts

Public ContactDr M Manjula

National Institute of Mental Health and Neurosciences

drmanjula71@gmail.com8026995182

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026